Pilot program aims to improve reproducibility, utility, and ethics of biomedical research

February 11, 2020

Addressing the widespread concern over transparency and reproducibility in biomedical research, one of the largest institutions in German science has begun to provide a framework, interventions, and incentives for improving the quality and value of translational research. The program is described by its leader, Ulrich Dirnagl of Berlin Institute of Health (BIH), and colleagues in a new article publishing on February 11 in the open-access journal PLOS Biology.

Despite the progress of modern biomedical science and approval of new drugs, there is a wide and growing recognition that the practice of biomedical research has significant weaknesses that lead to exorbitant waste, failed "breakthrough" treatments, and inability to replicate "landmark" findings. To address these concerns, the Berlin Institute of Health founded the QUEST Center for Transforming Biomedical Research, which developed the quality improvement program. The QUEST Center is implementing the program in BIH's two member institutions, Charité- Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine.

The program offers training, tools, and incentives to researchers to improve the quality of research, based on the principles of trustworthiness, usefulness, and ethics. For instance, the Center offers courses in reducing bias in research design, provides a guide to publishing negative or inconclusive findings, and offers financial rewards for making data publicly available. Program evaluations are ongoing and will be published in the near future.

"Conceptually, we are conducting and evaluating a large-scale behavior change intervention," said Dirnagl. "While such changes at a single institution can have little effect by themselves, we hope this program can provide a model for widespread adoption by other research institutions globally."
Peer-reviewed; Opinion piece; N/A

In your coverage please use this URL to provide access to the freely available article in PLOS Biology: https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3000576

Citation: Strech D, Weissgerber T, Dirnagl U, on behalf of QUEST Group (2020) Improving the trustworthiness, usefulness, and ethics of biomedical research through an innovative and comprehensive institutional initiative. PLoS Biol 18(2): e3000576. https://doi.org/10.1371/journal.pbio.3000576

Funding: The authors received no specific funding for this work.

Competing Interests: The authors have declared that no competing interests exist.


Related Biomedical Research Articles from Brightsurf:

General data protection regulation hinders global biomedical research
The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU.

Novel educational program puts a human face on biomedical research
The goal of translational research is to speed research breakthroughs into clinical practice.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.

World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.

Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Read More: Biomedical Research News and Biomedical Research Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.